<DOC>
	<DOCNO>NCT01186913</DOCNO>
	<brief_summary>People Primary Immune Deficiency ( PID ) may develop severe , life-threatening infection result inherit defect gene normally instruct blood-forming cell develop fight infection . PID diseases include Severe Combined Immune Deficiency ( SCID ) , leaky SCID , Omenn syndrome ( OS ) , Reticular Dysgenesis ( RD ) . PIDs may treat transplantation bone marrow stem cell healthy person , case , enzyme replacement gene therapy . Patients SCID among first receive bone marrow stem cell ( also call hematopoietic cell ) transplantation ( HCT ) 40 year ago , HCT standard treatment today group diseases . Since PID disease rare , enough patient single center determine full range cause , natural history , best method treatment . For research study many PID center across North America organize Primary Immune Deficiency Treatment Consortium ( PIDTC ) pool experience study PIDs together . The overall goal study prospective evaluation child SCID relate disorder treat variety protocol participate institution . The study aim identify variable contribute best outcomes HCT .</brief_summary>
	<brief_title>Natural History Study SCID Disorders</brief_title>
	<detailed_description />
	<mesh_term>Severe Combined Immunodeficiency</mesh_term>
	<criteria>Stratum A , Classic SCID Patients meet follow inclusion criterion intention treat allogeneic hematopoietic cell transplant ( HCT ) eligible enrollment Stratum A Absence low number ( &lt; 300 / ul ) T cell , AND low ( &lt; 10 % low limit normal ) T cell function ( measure response phytohemagglutinin OR T cell maternal origin present , &lt; 10 % low limit normal T cell function ( measure response PHA ) Stratum B , Leaky SCID , Omenn Syndrome , Reticular Dysgenesis Patients meet follow criterion intention treat HCT eligible enrollment Stratum B Leaky SCID : &lt; 1000 / ul T cell number &lt; age 2 year ; &lt; 800 / ul T cell number age 2 &lt; 4 year ; &lt; 600 / ul &gt; 4 year ; maternal lymphocyte detect , AND either one follow ruleout MHC Class I II nonexpression flow cytometry ( histology ) : 1 . ≥ 10 % ≤ 30 % low limit normal T cell function ( measure response PHA ) , b ) Absent proliferative response candida tetanus toxoid antigen ( post vaccination exposure ) , expression HLA flow/serology Omenn Syndrome : Generalized skin rash Maternal lymphocytes detect Absent low ( &lt; 30 % low limit normal ) T cell proliferation antigens &gt; 80 % CD4 T cell CD45RO+ ( &lt; 2 year age ) Reticular Dysgenesis : &lt; 300 / ul T cell number None &lt; 10 % low limit normal PHA proliferation Sensorineural deafness Severe neutropenia ( &lt; 200 / uL unresponsive GCSF ) deficiency marrow granulopoiesis unless know adenylate kinase 2 ( AK2 ) pathogenic mutation ( ) identify Stratum C , SCID NonHCT Treatments Patients meet following criterion intention treat PEGADA gene transfer autologous modify cell eligible enrollment Stratum C : ADA Deficient SCID intention treat PEGADA ADA Deficient SCID intention treat gene transfer Xlinked SCID intention treat gene transfer Patients meet one follow exclusion criterion disqualify enrollment Strata A , B , C study : Presence HIV infection ( PCR ) cause secondary immunodeficiency . Presence DiGeorge syndrome Most patient PIDs nucleoside phosphorylase deficiency , ZAP70 deficiency , CD40 ligand deficiency , NEMO deficiency , XLP , cartilage hair hypoplasia ataxia telangiectasia meet inclusion criterion Stratum A , B , C . However , patient one may meet inclusion criterion Stratum B include . MHC Class I MHC Class II antigen deficiency specifically exclude . Metabolic condition imitate SCID related disorder folate transporter deficiency , severe zinc deficiency , transcobalamin deficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>